EP Patent

EP4279062A1 — Liquid composition and its use, treatment method and kit

Assigned to EMS SA Brasil · Expires 2023-11-22 · 2y expired

What this patent protects

The present invention discloses new liquid compositions of lisdexamfetamine, their uses, kits and treatment methods for treating attention deficit hyperactivity disorder (ADHD) and binge eating disorder (BED).

USPTO Abstract

The present invention discloses new liquid compositions of lisdexamfetamine, their uses, kits and treatment methods for treating attention deficit hyperactivity disorder (ADHD) and binge eating disorder (BED).

Drugs covered by this patent

Patent Metadata

Patent number
EP4279062A1
Jurisdiction
EP
Classification
—
Expires
2023-11-22
Drug substance claim
No
Drug product claim
No
Assignee
EMS SA Brasil
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.